NY S04513 | 2023-2024 | General Assembly

Status

Spectrum: Partisan Bill (Democrat 4-0)
Status: Introduced on February 9 2023 - 25% progression
Action: 2024-05-15 - REPORTED AND COMMITTED TO FINANCE
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.

Sponsors


Roll Calls

2024-05-15 - Senate - Senate Health Committee Vote (Y: 13 N: 2 NV: 0 Abs: 0) [PASS]
2023-05-17 - Senate - Senate Health Committee Vote (Y: 13 N: 2 NV: 0 Abs: 0) [PASS]

History

DateChamberAction
2024-05-15SenateREPORTED AND COMMITTED TO FINANCE
2024-01-03SenateREFERRED TO HEALTH
2023-06-10SenateCOMMITTED TO RULES
2023-05-22SenateADVANCED TO THIRD READING
2023-05-18Senate2ND REPORT CAL.
2023-05-17Senate1ST REPORT CAL.1051
2023-02-09SenateREFERRED TO HEALTH

Same As/Similar To

A07465 (Same As) 2024-01-03 - referred to health

New York State Sources


Bill Comments

feedback